HealthcareVerified Seller

Business Valuation Formula in 2026: The 5 Methods and Math | CT Acquisitions

United States

Asking PriceUpon Request

Annual Revenue$3,500,000

EBITDA / Cash Flow$1,000,000

Executive Overview

Established healthcare acquisition opportunity based in United States. Delivering $3,500K in annual revenue with $1,000K in discretionary cash flow.

Key Investment Highlights

•Strong Market Position: Longstanding presence in United States with recurring customer base and reputable local brand.
•Financial Profile: Documented historical earnings with healthy operating margins and verifiable tax returns.
•Turnkey Infrastructure: Fully equipped operational facilities, experienced team, and documented operating procedures.
•Financing Eligibility: Structure suitable for SBA 7(a) acquisition financing with qualifying down payment.
•Growth Potential: Clear expansion opportunities through digital customer acquisition and adjacent service offerings.

# The Business Valuation Formula in 2026: The 5 Methods, the Math, and When Each Formula Actually Applies There is no single business valuation formula that fits every company, every buyer, and every deal. There are five core formulas (EBITDA multiple, SDE multiple, DCF, asset-based, comparable transactions), each ans

Confidential CIM Access

Request Full Diligence Package

Due to seller confidentiality, detailed balance sheets, customer concentration, tax returns, and supplier agreements require executing our digital bilateral NDA.

Business Valuation Formula in 2026: The 5 Methods and Math | CT Acquisitions

Executive Overview

Key Investment Highlights

Request Full Diligence Package

Evaluating this deal?